ClinicalTrials.govpublic full text
Vunakizumab for the Treatment of Mild to Moderate Systemic Lupus Erythematosus
lupus erythematosus, systemic, vunakizumab, systemic lupus erythematosus, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 970048
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.